Avidity Biosciences, Inc. (RNA)
USD 26.7
(-4.98%)
USD 26.7
(-4.98%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -175.23 Million USD | 46.85% |
| 2022 | -329.7 Million USD | 16.65% |
| 2021 | -395.58 Million USD | -20.9% |
| 2020 | -327.2 Million USD | -265.01% |
| 2019 | -89.64 Million USD | -1339.16% |
| 2018 | 7.23 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -462.25 Million USD | -163.8% |
| 2024 Q2 | -567.36 Million USD | -22.74% |
| 2023 FY | -175.23 Million USD | 46.85% |
| 2023 Q2 | -144.36 Million USD | -29.21% |
| 2023 Q1 | -111.73 Million USD | 66.11% |
| 2023 Q3 | -75.06 Million USD | 48.0% |
| 2023 Q4 | -175.23 Million USD | -133.43% |
| 2022 Q1 | -127.37 Million USD | 67.8% |
| 2022 FY | -329.7 Million USD | 16.65% |
| 2022 Q3 | -132.42 Million USD | -16.89% |
| 2022 Q2 | -113.28 Million USD | 11.06% |
| 2022 Q4 | -329.7 Million USD | -148.98% |
| 2021 Q4 | -395.58 Million USD | 3.31% |
| 2021 FY | -395.58 Million USD | -20.9% |
| 2021 Q1 | -300.32 Million USD | 8.22% |
| 2021 Q2 | -275.5 Million USD | 8.26% |
| 2021 Q3 | -409.13 Million USD | -48.5% |
| 2020 Q3 | -340.45 Million USD | 3.22% |
| 2020 FY | -327.2 Million USD | -265.01% |
| 2020 Q1 | -84.57 Million USD | 5.65% |
| 2020 Q4 | -327.2 Million USD | 3.89% |
| 2020 Q2 | -351.76 Million USD | -315.92% |
| 2019 FY | -89.64 Million USD | -1339.16% |
| 2019 Q4 | -89.64 Million USD | 0.0% |
| 2019 Q1 | 3.09 Million USD | 0.0% |
| 2018 FY | 7.23 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -213.246% |
| Alkermes plc | -166.73 Million USD | -5.092% |
| Agenus Inc. | 274.13 Million USD | 163.921% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 109.371% |
| Aptorum Group Limited | 1.35 Million USD | 13012.606% |
| Ardelyx, Inc. | 34.51 Million USD | 607.736% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4194.159% |
| Bicycle Therapeutics plc | -481.46 Million USD | 63.605% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 584.556% |
| ChromaDex Corporation | -24.04 Million USD | -628.668% |
| Chimerix, Inc. | -25.51 Million USD | -586.719% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2614.754% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -640.085% |
| CRISPR Therapeutics AG | -150.84 Million USD | -16.166% |
| Precision BioSciences, Inc. | -85.41 Million USD | -105.163% |
| Dyadic International, Inc. | -6.37 Million USD | -2647.37% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -999.793% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2386.106% |
| Lantern Pharma Inc. | -21.7 Million USD | -707.39% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -58.526% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1951.111% |
| Incyte Corporation | -3.17 Billion USD | 94.481% |
| IO Biotech, Inc. | -140.69 Million USD | -24.542% |
| Jaguar Health, Inc. | 29.39 Million USD | 696.203% |
| Novavax, Inc. | -298.29 Million USD | 41.256% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3383.305% |
| Opthea Limited | 28.15 Million USD | 722.322% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -943.719% |
| ContextLogic Inc. | -232 Million USD | 24.47% |
| MiMedx Group, Inc. | -33.9 Million USD | -416.887% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1818.784% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -7462.709% |
| NextCure, Inc. | -6.47 Million USD | -2605.419% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -246.983% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2646.982% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1540.649% |
| Vaxcyte, Inc. | -368.22 Million USD | 52.413% |
| PDS Biotechnology Corporation | -32.7 Million USD | -435.726% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1114.18% |
| Pharming Group N.V. | 109.8 Million USD | 259.584% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -907.301% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -846.174% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -846.174% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2368.028% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2890.273% |
| Acelyrin, Inc. | -216.9 Million USD | 19.213% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3023.381% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -10064.153% |
| Summit Therapeutics Inc. | 34.67 Million USD | 605.364% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2475.775% |
| Senti Biosciences, Inc. | 1.74 Million USD | 10170.69% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 5.079% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -126.246% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2790.63% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 175735.719% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 28002.866% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -49.71% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -4.159% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 258.05% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2206.872% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -35.717% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2641.555% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 27.699% |
| Immix Biopharma, Inc. | -17.5 Million USD | -900.754% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 44.671% |
| MEI Pharma, Inc. | -3.7 Million USD | -4629.555% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1500.607% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 208.339% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 730.482% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2386.106% |
| Precigen, Inc. | -481 Thousand USD | -36330.353% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1344.443% |
| AlloVir, Inc. | -62.69 Million USD | -179.509% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -215.083% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 384.16% |
| ImmuCell Corporation | 10.99 Million USD | 1694.368% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -13.678% |
| Onconetix, Inc. | 5.33 Million USD | 3386.731% |
| PureTech Health plc | -167.19 Million USD | -4.805% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -475.279% |
| Elevation Oncology, Inc. | -19.11 Million USD | -816.571% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3469.566% |
| Seer, Inc. | -4.24 Million USD | -4032.783% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -629.001% |
| Innoviva, Inc. | 255.56 Million USD | 168.566% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -213.672% |
| ESSA Pharma Inc. | -33.62 Million USD | -421.183% |
| GlycoMimetics, Inc. | -40.98 Million USD | -327.553% |
| GT Biopharma, Inc. | -1.02 Million USD | -17062.586% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -158.516% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 386.057% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -30.692% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1164.651% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -506.92% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -232504.136% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -467.786% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2038.292% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -5500.16% |
| Soligenix, Inc. | -4.95 Million USD | -3438.858% |
| Century Therapeutics, Inc. | 847 Thousand USD | 20788.312% |
| Kura Oncology, Inc. | -20.11 Million USD | -771.011% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -328.163% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1986.568% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 9719.064% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -5381.076% |
| Autolus Therapeutics plc | -186.59 Million USD | 6.093% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -255.407% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 36.463% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 611.352% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 206.608% |
| GRI Bio, Inc. | -1.79 Million USD | -9667.559% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1850.675% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -426.897% |
| IGM Biosciences, Inc. | -72.6 Million USD | -141.344% |
| INmune Bio, Inc. | -25.41 Million USD | -589.583% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 216.084% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -245.901% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -978.38% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -5973.986% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 560.95% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -325.47% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 649.569% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 146.363% |
| Verastem, Inc. | -37.27 Million USD | -370.063% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1831.335% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -237.877% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1057.78% |
| Histogen Inc. | -7.48 Million USD | -2240.457% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -710.994% |
| Surrozen, Inc. | -32.66 Million USD | -436.462% |
| Organovo Holdings, Inc. | -1.5 Million USD | -11527.737% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4068.681% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1024.199% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 6798.394% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4316.314% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1990.763% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -303.365% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1102.111% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 44.686% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -24168.066% |
| Apollomics, Inc. | -27.39 Million USD | -539.642% |
| Amarin Corporation plc | -191.04 Million USD | 8.276% |
| Mesoblast Limited | 55.96 Million USD | 413.118% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1101.522% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -592.828% |
| Synaptogenix, Inc. | -28.66 Million USD | -511.378% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -18621.154% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 459.579% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -20226.208% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2311.617% |
| Exelixis, Inc. | -73.05 Million USD | -139.877% |
| Better Therapeutics, Inc. | -860 Thousand USD | -20275.581% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -629.73% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 27.402% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 23906.289% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2255.832% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 14073.684% |
| Gritstone bio, Inc. | 39.49 Million USD | 543.733% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -108.357% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -6557.321% |
| Avid Bioservices, Inc. | 169.72 Million USD | 203.242% |
| Insmed Incorporated | 721.62 Million USD | 124.283% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1816.86% |
| MediWound Ltd. | -5.32 Million USD | -3192.559% |
| OmniAb, Inc. | 9.2 Million USD | 2004.053% |
| Alector, Inc. | -35.63 Million USD | -391.708% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 303.825% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3455.804% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1423.589% |
| Zai Lab Limited | -775 Million USD | 77.39% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 151.454% |
| Aura Biosciences, Inc. | -21.52 Million USD | -714.077% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -112.452% |
| Immunic, Inc. | -45.34 Million USD | -286.48% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 9.308% |
| Veracyte, Inc. | -203.82 Million USD | 14.029% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 127.453% |
| FibroGen, Inc. | 56.76 Million USD | 408.683% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2067.771% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -6098.264% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -8363.794% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 103.817% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -5144.837% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -5.583% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1081.021% |
| Galecto, Inc. | -21.21 Million USD | -725.933% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -636.725% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 111.165% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -616.043% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1422.812% |
| XBiotech Inc. | -200.02 Million USD | 12.395% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -108.357% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3969.92% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -396.923% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -126.929% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3179.072% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -2.825% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -89.696% |
| Vaxxinity, Inc. | 10.13 Million USD | 1829.471% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 123.8% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1527.39% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -165.677% |
| NexImmune, Inc. | -3.13 Million USD | -5491.894% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -4975.198% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1059.584% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -546.605% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1852.194% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -140562.252% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -331.899% |
| Ainos, Inc. | 4.07 Million USD | 4397.035% |
| Pluri Inc. | 22.82 Million USD | 867.576% |
| Prothena Corporation plc | -608.34 Million USD | 71.196% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -47.555% |
| Celularity Inc. | 65.19 Million USD | 368.799% |
| Rallybio Corporation | -24.1 Million USD | -627.035% |
| Cue Biopharma, Inc. | -33.81 Million USD | -418.141% |
| MeiraGTx Holdings plc | -40.3 Million USD | -334.792% |
| Omeros Corporation | 331.17 Million USD | 152.911% |
| Humacyte, Inc. | -22.48 Million USD | -679.285% |
| Immunocore Holdings plc | -358.59 Million USD | 51.134% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -613.042% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -467.069% |
| Blueprint Medicines Corporation | 702.83 Million USD | 124.932% |
| CalciMedica, Inc. | -5.53 Million USD | -3068.716% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 6.901% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1615.586% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -337.67% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -426.96% |
| Pulmatrix, Inc. | -10.41 Million USD | -1582.154% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2831.738% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -359.415% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -57.295% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -192.323% |
| Cytokinetics, Incorporated | 642.37 Million USD | 127.279% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2909.274% |
| Nutriband Inc. | -251.65 Thousand USD | -69530.489% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -413.585% |
| Vor Biopharma Inc. | 4.3 Million USD | 4175.116% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.097% |
| Evogene Ltd. | -19.63 Million USD | -792.482% |
| ProKidney Corp. | -56.23 Million USD | -211.598% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -260.022% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1797.006% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 112.848% |
| CorMedix Inc. | -43.05 Million USD | -307.015% |
| BioLineRx Ltd. | 7.33 Million USD | 2488.631% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -538.012% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 479.721% |
| Atai Life Sciences N.V. | -28.55 Million USD | -513.593% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 7955.984% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -668.014% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1088.046% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -133.41% |
| MediciNova, Inc. | -50.78 Million USD | -245.053% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -122.359% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -778873.105% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2615.654% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 12.307% |
| Biomea Fusion, Inc. | -166.57 Million USD | -5.199% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 2.092% |
| Mereo BioPharma Group plc | -51.46 Million USD | -240.457% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -84.756% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 40.349% |
| Absci Corporation | -72.59 Million USD | -141.37% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3937.714% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 25.255% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -85.997% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -83.111% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -348.468% |
| Allakos Inc. | -24.97 Million USD | -601.622% |
| Imunon, Inc. | -4.21 Million USD | -4058.428% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1088.645% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -29.417% |
| BioAtla, Inc. | -109.01 Million USD | -60.745% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 23906.289% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -18561.342% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1564.399% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -726.44% |
| XOMA Corporation | -29 Million USD | -504.241% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -958.152% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1843.545% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2252.396% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -40.593% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 15.821% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -114.273% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -88.901% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -20294.933% |
| Akari Therapeutics, Plc | -3.84 Million USD | -4457.347% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 10897.405% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 112.69% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -14648.324% |
| UroGen Pharma Ltd. | 4.39 Million USD | 4090.663% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 254.414% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 243603.516% |
| Orgenesis Inc. | 21.78 Million USD | 904.398% |
| Entera Bio Ltd. | -10.62 Million USD | -1548.603% |
| GH Research PLC | -78.07 Million USD | -124.432% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -686.208% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -557.301% |
| Xencor, Inc. | 29.64 Million USD | 691.115% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -8795.773% |
| Replimune Group, Inc. | 1.41 Million USD | 12510.057% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -71449.316% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -38.613% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -14648.324% |
| Portage Biotech Inc. | -4.98 Million USD | -3417.968% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -778873.105% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -165.01% |
| OncoCyte Corporation | -6.56 Million USD | -2569.968% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 19626.127% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -3746.438% |
| Purple Biotech Ltd. | -14.13 Million USD | -1139.426% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -637.624% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2577.311% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -949.774% |
| HilleVax, Inc. | -165.48 Million USD | -5.889% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -6804.255% |
| Tharimmune, Inc. | -10.93 Million USD | -1502.418% |
| Genprex, Inc. | -6.73 Million USD | -2500.767% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 52.487% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -98.09% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -12407.495% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -5182.872% |
| OKYO Pharma Limited | -826.84 Thousand USD | -21092.529% |
| Savara Inc. | 153 Thousand USD | 114629.412% |
| Curis, Inc. | -23.88 Million USD | -633.579% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3297.306% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -22480.836% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2722.648% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 14887.342% |
| BeiGene, Ltd. | -2.25 Billion USD | 92.223% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1520.189% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 71.189% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 5.58% |
| Erasca, Inc. | -37.21 Million USD | -370.846% |
| bluebird bio, Inc. | 108.57 Million USD | 261.397% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -13505.944% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 146.266% |
| DBV Technologies S.A. | -126.98 Million USD | -37.992% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -13505.944% |
| Moderna, Inc. | -2.9 Billion USD | 93.972% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1592.716% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1512.348% |
| Molecular Templates, Inc. | 707 Thousand USD | 24885.007% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -458.573% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 150.556% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -113.534% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -91.028% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -442.978% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -409.745% |
| MacroGenics, Inc. | -66.98 Million USD | -161.596% |
| RenovoRx, Inc. | -1.17 Million USD | -14838.619% |
| Adicet Bio, Inc. | -138.78 Million USD | -26.258% |
| Prime Medicine, Inc. | -27.94 Million USD | -527.143% |
| Aditxt, Inc. | 18.12 Million USD | 1067.006% |
| Adagene Inc. | -87.62 Million USD | -99.972% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4106.771% |
| Quantum-Si incorporated | -118.55 Million USD | -47.802% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 586.682% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2244.469% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -261.232% |
| SciSparc Ltd. | -2.06 Million USD | -8385.714% |
| Vericel Corporation | 1.27 Million USD | 13822.005% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1361.261% |
| Minerva Neurosciences, Inc. | 41 Million USD | 527.346% |
| Generation Bio Co. | 31.44 Million USD | 657.206% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 0.076% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -466.666% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 250.292% |
| Invivyd, Inc. | -198.47 Million USD | 11.712% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -94.118% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -7208.289% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -147.535% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2467.473% |
| 2seventy bio, Inc. | 181.71 Million USD | 196.431% |
| ADMA Biologics, Inc. | 90.06 Million USD | 294.557% |
| Clene Inc. | 3.34 Million USD | 5346.407% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1829.271% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -714.606% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2615.654% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 49.079% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -573.97% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 198.629% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4182.711% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3603.199% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3263.985% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -34.478% |
| Evaxion Biotech A/S | 5.28 Million USD | 3414.454% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -55.666% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -33.485% |
| Trevena, Inc. | 2.25 Million USD | 7860.407% |
| Surrozen, Inc. | -32.66 Million USD | -436.462% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -240.186% |
| Cingulate Inc. | 3.08 Million USD | 5784.334% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -5866.292% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2538.152% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1785.973% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -120.907% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -33.303% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -66.029% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4344.487% |
| Kronos Bio, Inc. | -36.05 Million USD | -386.021% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1962.366% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 12117.472% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -222.969% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1315.49% |
| ImmunityBio, Inc. | 618.22 Million USD | 128.344% |
| Korro Bio, Inc. | -132.94 Million USD | -31.808% |
| Kineta, Inc. | -4.54 Million USD | -3758.842% |
| BioVie Inc. | -17.73 Million USD | -888.194% |
| Codexis, Inc. | -43.27 Million USD | -304.959% |
| Celularity Inc. | 65.19 Million USD | 368.799% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -5429.505% |
| Celcuity Inc. | 6.78 Million USD | 2683.176% |
| Virax Biolabs Group Limited | -3.36 Million USD | -5107.516% |
| Cibus, Inc. | -8.07 Million USD | -2069.225% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -4043.533% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 3934.354% |
| IN8bio, Inc. | -16.38 Million USD | -969.193% |
| Kodiak Sciences Inc. | -103.87 Million USD | -68.693% |
| Annexon, Inc. | -193.75 Million USD | 9.561% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 486850.0% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -901.372% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -4888.044% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 116.621% |
| Eyenovia, Inc. | 1.25 Million USD | 14021.484% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 751.292% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5303.33% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -427.055% |
| Arcellx, Inc. | -296.95 Million USD | 40.992% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -798.339% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -197.631% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -745.419% |
| Moolec Science SA | 117.61 Thousand USD | 149084.832% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -356.34% |
| Geron Corporation | 14.76 Million USD | 1287.115% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -362.129% |
| Royalty Pharma plc | 5.65 Billion USD | 103.097% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -23.907% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2407.074% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3167.474% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -24.514% |
| Humacyte, Inc. | -22.48 Million USD | -679.285% |
| Structure Therapeutics Inc. | -124.33 Million USD | -40.929% |
| 89bio, Inc. | -289.05 Million USD | 39.378% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -594.2% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -9727.818% |
| Genelux Corporation | -6.89 Million USD | -2439.933% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -464.184% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 309.608% |
| Notable Labs, Ltd. | -9.77 Million USD | -1692.451% |
| Liquidia Corporation | -80.17 Million USD | -118.557% |
| Mustang Bio, Inc. | -3.73 Million USD | -4590.31% |
| Immunovant, Inc. | -635.22 Million USD | 72.415% |
| Quantum-Si incorporated | -118.55 Million USD | -47.802% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -897.666% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -4129.544% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2283.007% |
| Acasti Pharma Inc. | -23 Million USD | -661.704% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -5103.982% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -978.38% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -27.218% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -5522.903% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -688.188% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -843.67% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -3.516% |
| PepGen Inc. | -60.67 Million USD | -188.825% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -662.665% |
| United Therapeutics Corporation | -507.7 Million USD | 65.486% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -816.187% |
| Solid Biosciences Inc. | -47.75 Million USD | -266.974% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -20226.208% |
| Immuneering Corporation | -54.94 Million USD | -218.931% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4068.681% |
| Silo Pharma, Inc. | -3.52 Million USD | -4872.04% |
| Belite Bio, Inc | -87.27 Million USD | -100.788% |
| XOMA Corporation | -29 Million USD | -504.241% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -147.861% |
| Bionomics Limited | 227 Million USD | 177.19% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -50.694% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6817.884% |
| uniQure N.V. | -102.95 Million USD | -70.207% |
| Cassava Sciences, Inc. | -121.13 Million USD | -44.656% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4106.771% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 527.902% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1365.011% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -5563.176% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 165411.321% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5303.33% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2067.771% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2262.864% |
| Altimmune, Inc. | -134.48 Million USD | -30.295% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 188.471% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6817.884% |
| Compugen Ltd. | -12.9 Million USD | -1257.951% |
| Peak Bio, Inc. | 10.34 Million USD | 1794.655% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -61818.728% |
| Benitec Biopharma Inc. | -50.58 Million USD | -246.428% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -67.945% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 991.983% |
| Zura Bio Limited | -99.8 Million USD | -75.571% |
| PolyPid Ltd. | 6.17 Million USD | 2940.032% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 336.414% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 991.983% |
| Instil Bio, Inc. | 75.35 Million USD | 332.53% |
| argenx SE | -2.02 Billion USD | 91.363% |
| Immunome, Inc. | -97.02 Million USD | -80.595% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -678.973% |
| Verona Pharma plc | -220.44 Million USD | 20.51% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -144.247% |
| Shattuck Labs, Inc. | -121.42 Million USD | -44.312% |
| CervoMed Inc. | -7.79 Million USD | -2148.601% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 5.536% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -3907.089% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -33.012% |
| Moolec Science SA | 117.61 Thousand USD | 149084.832% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -7558.731% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1202.188% |
| AnaptysBio, Inc. | -18.15 Million USD | -865.401% |
| Design Therapeutics, Inc. | -18.15 Million USD | -865.455% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -148.973% |
| NeurAxis, Inc. | 145.7 Thousand USD | 120367.673% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1660.096% |
| Lumos Pharma, Inc. | -28.49 Million USD | -514.993% |
| Achilles Therapeutics plc | -126.92 Million USD | -38.059% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -144.247% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -26622.889% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -743.513% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 12117.472% |
| Nutriband Inc. | -251.65 Thousand USD | -69530.489% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1230.423% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2255.242% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 151.508% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 838.277% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 60.84% |
| Palisade Bio, Inc. | -12.06 Million USD | -1352.624% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -24.887% |
| Beam Therapeutics Inc. | -262.72 Million USD | 33.302% |
| Neurogene Inc. | -131.95 Million USD | -32.795% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 903.218% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3490.779% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 53.543% |
| Sesen Bio, Inc. | -112.55 Million USD | -55.687% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -75.476% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -7363.605% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -349.008% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -110.406% |
| Athira Pharma, Inc. | -88.99 Million USD | -96.89% |
| Vaccinex, Inc. | -1.28 Million USD | -13504.814% |
| HCW Biologics Inc. | 2.85 Million USD | 6234.052% |
| XOMA Corporation | -29 Million USD | -504.241% |
| Nektar Therapeutics | 210.24 Million USD | 183.348% |
| Arvinas, Inc. | -313.8 Million USD | 44.159% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 10897.405% |
| Merus N.V. | -192.88 Million USD | 9.153% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 392.123% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2425.656% |
| Rezolute, Inc. | -68.16 Million USD | -157.056% |
| Clene Inc. | 3.34 Million USD | 5346.407% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1228.809% |
| BeyondSpring Inc. | -13.75 Million USD | -1173.937% |
| Synlogic, Inc. | -6.68 Million USD | -2521.242% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 15552.381% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1972.501% |
| Peak Bio, Inc. | 10.34 Million USD | 1794.655% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -112.606% |
| Krystal Biotech, Inc. | -350.23 Million USD | 49.968% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 241.172% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -3.689% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -5450.269% |
| MannKind Corporation | 143.89 Million USD | 221.773% |
| Ikena Oncology, Inc. | -109.15 Million USD | -60.532% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2214.489% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -429.396% |
| Gossamer Bio, Inc. | 180.35 Million USD | 197.158% |
| CohBar, Inc. | -5.93 Million USD | -2854.61% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -489.048% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3937.714% |
| Legend Biotech Corporation | -949.39 Million USD | 81.543% |
| Mural Oncology plc | -255.84 Million USD | 31.509% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 643.939% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -3619.875% |
| Disc Medicine, Inc. | -358.28 Million USD | 51.091% |
| Champions Oncology, Inc. | 4.81 Million USD | 3741.521% |
| REGENXBIO Inc. | 54.76 Million USD | 419.95% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -65063.793% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -16.028% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1844.406% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -117.183% |
| Vaxart, Inc. | -8.24 Million USD | -2026.32% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -249.203% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -37.797% |
| Cellectis S.A. | -43.85 Million USD | -299.567% |
| Longeveron Inc. | -2.9 Million USD | -5925.791% |
| Repare Therapeutics Inc. | -107.85 Million USD | -62.464% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 118.095% |
| Inozyme Pharma, Inc. | 12 Million USD | 1559.763% |
| Revolution Medicines, Inc. | -608.2 Million USD | 71.189% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -14146.341% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 33.905% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -16.764% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1019.895% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -23579.73% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.168% |
| Denali Therapeutics Inc. | -74.86 Million USD | -134.061% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1361.261% |
| Veru Inc. | 4.77 Million USD | 3765.923% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1458.154% |
| Cingulate Inc. | 3.08 Million USD | 5784.334% |
| Passage Bio, Inc. | 4.58 Million USD | 3921.81% |
| Context Therapeutics Inc. | -14.44 Million USD | -1112.679% |
| Exicure, Inc. | 5.84 Million USD | 3095.897% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 23.937% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -342.835% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1216.755% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -197.904% |
| Nuvalent, Inc. | -335.38 Million USD | 47.753% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 10203.549% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -135.265% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1871.091% |
| OmniAb, Inc. | 9.2 Million USD | 2004.053% |
| Anew Medical, Inc. | 1.43 Million USD | 12332.76% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1169.666% |
| Lipocine Inc. | -4.75 Million USD | -3585.49% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -59.549% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1250.483% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -245.901% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 803.961% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2507.201% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -166.198% |
| Ocugen, Inc. | -32.52 Million USD | -438.821% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -104.768% |
| Q32 Bio Inc. | -37.94 Million USD | -361.763% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -27802.866% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1195.218% |
| Equillium, Inc. | -22.39 Million USD | -682.556% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -585.349% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -437.074% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -70581.484% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 230.728% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 5579.362% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 53452.048% |
| Dominari Holdings Inc. | 195 Thousand USD | 89961.538% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3226.998% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1865.123% |
| Bio-Techne Corporation | 267.74 Million USD | 165.446% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -981.066% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -48.382% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1985.327% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1285.108% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 28.512% |
| Nkarta, Inc. | 57.29 Million USD | 405.817% |
| BioCardia, Inc. | 212 Thousand USD | 82755.66% |
| Iterum Therapeutics plc | 13.43 Million USD | 1403.989% |